Infectious Pathogens in Acute Respiratory Illness in Adults and Elderly

NCT01360398 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 127

Last updated 2019-02-15

Study results available
· View outcomes & findings →

Summary

The aim of this study is to generate epidemiological data to further explore determinants of Chronic Obstructive Pulmonary Disease (COPD) and the contribution of bacterial and viral pathogens to Acute Exacerbation of COPD (AECOPD) episodes.

Conditions

Interventions

PROCEDURE

Blood sample

Blood samples will be collected from all patients at enrolment, at follow-up visits, at exacerbation visits, and during the final visit.

PROCEDURE

Sputum sample

Sputum will be collected from all patients at enrolment, at monthly follow-up visits, at exacerbation visits, and during the final visit. Sputum will be obtained by spontaneous expectoration or induced by stimulation according to standard methods.

PROCEDURE

Nasopharyngeal swab

Nasopharyngeal swabs will be collected from all patients at enrolment and from a subcohort of 30 patients at monthly follow-up visits and at exacerbation visits during the first year.

PROCEDURE

Urine sample

Urine samples will be taken at enrolment and exacerbation visits from all subjects and from the same subcohort of 30 patients providing nasopharyngeal swabs, at monthly follow-up visits during the first year.

PROCEDURE

End tidal breath sample

Breath samples will be collected from all patients at enrolment, at follow-up visits (monthly), at exacerbation visits, and during the final visit.

OTHER

Data collection

Patient interview, diary cards review and questionnaires completion

OTHER

Tests

Urine pregnancy test, chest CT-scan, lung function testing and 6-min walk test

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2014-06-27
Completion
2014-06-27

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01360398 on ClinicalTrials.gov